ROBERT LIEN: Open Payments
NPI 1821578956 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$547 in 32 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $547
Food & beverage: $547
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 10 | $144 |
| AstraZeneca Pharmaceuticals LP | 8 | $138 |
| Novo Nordisk Inc | 7 | $116 |
| GENZYME CORPORATION | 3 | $65 |
| Dexcom, Inc. | 2 | $46 |
| Inspire Medical Systems, Inc. | 1 | $24 |
| PFIZER INC. | 1 | $14 |
Products named: Ozempic, MOUNJARO, BREZTRI, FARXIGA, KISUNLA, Dexcom G6 Transmitter, FABRAZYME, INSPIRE.
Industry payments across MO — which companies pay providers there.
